HIGHLIGHTS
- who: Roman A. Beltran and colleagues from the DepartmentMidwestern University Glendale, AZ, USA have published the article: Is a PCSK9 Inhibitor Right for Your Patient? A Review of Treatment Data for Individualized Therapy, in the Journal: (JOURNAL)
- what: In this review, these options were explored, with a focus on PCSK9 inhibitors. The non-statin treatment that has become the focus of this literature review and treatment evaluation is PCSK-9 inhibitors. The primary findings of the study showed a significant association between baseline PCSK9 levels and 10-year progression of carotid atherosclerosis. At the start . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.